Target RWE, a leading real-world evidence solutions company, today announced the results of an innovative research study validating the new nomenclature for fatty liver disease in pediatric patients.

As the technology continues to improve and more quantum applications are developed we expect to see increasingly more ...

ZUG, Switzerland and SAN JUAN, Puerto Rico and TORONTO, Nov. 25, 2024 (GLOBE NEWSWIRE) -- Aphaia Pharma, a clinical-stage ...

KEY POINTS A 72-year-old man presented to the emergency department with a 2-week history of hypotension, postural dizziness, and muscle weakness. He had a medical history of HIV, lipodystrophy, ...

According to Means, roughly 93% of US adults have "Bad Energy," or poor metabolic health. She attributes conditions like ...

Though carb cycling, along with things like intermittent fasting and body recomposition, used to be a dietary concept ...

AstraZeneca faces challenges in securing full FDA approval for Andexxa, its anticoagulant reversal therapy, due to safety ...

Yvonne Karney, MD, a Functional and Integrative Medical Doctor, recently joined Gayle Guyardo on the globally syndicated ...

Austin, Nov. 19, 2024 (GLOBE NEWSWIRE) -- The S&S Insider report indicates that, “ The Glycomics Market was valued at USD 1.68 Billion in 2023 and is projected to reach USD 5.33 Billion by 2032, ...

Join the debate on weight loss drugs at NAILBA 43. Experts discuss the risk factors and effectiveness of GLP-1 drugs like Ozempic.

Biochemical measurements were taken to evaluate serum magnesium levels and other metabolic markers, while MetS was diagnosed ...

There is a growing consumer interest in alternative proactive solutions for cardiovascular disease (CVD), as evidenced by the ...